AIkido Pharma (NASDAQ:AIKI) Stock Price Down 11.9% – Here’s Why

AIkido Pharma Inc. (NASDAQ:AIKI)’s share price was down 11.9% on Friday. The company traded as low as $1.4101 and last traded at $1.4450. 323,970 shares changed hands during mid-day trading, an increase of 308% from the average session volume of 79,326 shares. The stock had previously closed at $1.64.

AIkido Pharma Trading Down 11.9%

The company has a market cap of $7.93 million, a price-to-earnings ratio of -0.37 and a beta of 0.93. The stock’s 50-day moving average is $2.09 and its 200-day moving average is $2.86.

AIkido Pharma Company Profile

AIkido Pharma Inc is a development-stage biotechnology company focused on discovering and developing therapeutic products for serious diseases. Its activities have centered primarily on small-molecule drug candidates and early-stage pharmaceutical research rather than the sale of commercialized products.

The company has historically pursued programs in oncology, including research related to pancreatic cancer, as well as potential treatments for infectious diseases. AIkido Pharma has used licensing arrangements, research collaborations and other external partnerships to advance its development pipeline.

AIkido Pharma’s programs have generally remained in the preclinical or early development stages, and the company’s operations have been focused on research and development rather than broad commercial distribution.